Neurogene (NGNE) Provides Update on NGN-401 Gene Therapy Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. TRMD
9. ACN
10. AZN

Go back to Neurogene (NGNE) Provides Update on NGN-401 Gene Therapy Trial
(NASDAQ: NGNE) Delayed: 32.09 -0.32 (0.99%)
Previous Close $32.41    52 Week High $ 
Open $32.49    52 Week Low $ 
Day High $33.15    P/E N/A 
Day Low $31.86    EPS $ 
Volume 1,388,879